|
Backed by direct scientific research with elite collegiate and youth athletes, CryoTherm Palm's cooling technology made its debut with the England national team supporting training camps, pre-tournament friendlies, and sideline recovery protocols
LOS ANGELES, June 8, 2026 /PRNewswire/ -- Therabody®, the global wellness technology leader, today announced the launch of CryoTherm Palm, marking both a new addition to the brand's performance line and its entrance into the emerging thermoregulation category. CryoTherm Palm is the only palm cooling device validated through two controlled studies with statistically significant results ahead of its launch, delivering science-backed palm cooling that lowers core body temperature between high-intensity efforts to delay fatigue, reduce perceived exertion, and sustain output.
CryoTherm Palm is a portable, cordless device with dual cooling surfaces, for each palm, engineered for use during natural rest periods between sets, at halftime, during timeouts, water breaks, or across any high-intensity interval training or competition. Therabody's proprietary Cryothermal technology delivers scientifically calibrated cooling that maintains a therapeutic temperature range for the full duration of treatment, with no ice, water, or setup. Beyond palm cooling, it also delivers localized cold therapy, localized heat therapy, and contrast therapy, giving athletes and performance staff a single device for both in-session performance and post-session recovery.
Additional CryoTherm Palm features:
- Three scientifically calibrated cold temperature levels (46.4°F / 8°C, 53.6°F / 12°C, 60.8°F / 16°C) powered by proprietary Cryothermal Technology
- LCD display with stopwatch for treatment duration tracking and temperature status indicators
- Setting memory recalls last-used settings for quick start
- Up to 120 minutes of battery life; charges via USB-C
- Anti-roll, portable design with travel lock and included travel pouch
- Learn more about the science and technology behind CryoTherm Palm on Therabody's blog
The launch comes as elite athletes prepare to compete in summer heat, where managing body temperature and recovery can be critical to performance. England's national football team has incorporated CryoTherm Palm into its pre-tournament preparations, using the device throughout training camp ahead of the upcoming matches.
CryoTherm Palm is the only palm cooling device validated in two controlled studies: one with Division I athletes at the University of Southern California focused on strength training, and a second with elite soccer players at IMG Academy performing repeated sprint efforts. The results uncovered:
- 28% more total work volume during resistance training vs. control*
- 58% more reps in the final set vs. control*
- 7% increase in post-session grip strength vs. control*
- Athletes felt 60% cooler during repeated sprint efforts**
- 2.45% increase in top sprint speed vs. control**
- 4.7% better sprint velocity maintained across repeated all-out efforts**
- More information on the study findings can be found in the following research summaries: Therabody x University of Southern California, Therabody x IMG Academy
"Our mission has always been to help people feel better and perform at their best," says Tim Roberts, Chief Science Officer, Therabody. "CryoTherm Palm extends that mission into the training session itself—helping athletes delay fatigue, sustain intensity, and get more out of every effort. Whether it's a soccer player staying dangerous in the 85th minute or a strength athlete pushing through a final set, this product was designed and proven to make a measurable difference."
CryoTherm Palm is TSA compliant and registered as a Class 2 Exempt Medical Device in the United States and a Class 2 Medical Device in Canada. The product is available for purchase now at an MSRP of $399.99 in the United States on Therabody.com, with international availability in the EU, UK, Australia, and Canada coming fall 2026.
ABOUT THERABODY
Therabody® is the global wellness technology leader with a mission to empower every body to feel better and move better. Founded by Dr. Jason Wersland in 2016, the company combines science, innovation, and design to create products that optimize human performance and recovery. Recognized as one of Fast Company's Most Innovative Companies of 2026 and TIME's Best Inventions of 2025, Therabody continues to set the standard for wellness innovation. Its ecosystem includes the Theragun, JetBoots, PowerDot, TheraFace, and TheraCup, as well as digital wellness content and in-person experiences through Reset® by Therabody. For more information, visit Therabody.com or follow @Therabody on social media.
*Results from a randomized crossover study conducted with University of Southern California involving D1 collegiate athletes (n = 21) performing 4 sets of overhead presses to failure at 85% 1RM, with a single inter-set CryoTherm™ Palm application between sets. Results compare intervention to control conditions and may not reflect outcomes in other training contexts, athlete levels, or populations. Full study details at therabody.com/science.
**Results from a randomized crossover study conducted at IMG Academy in collaboration with University of Florida involving elite male soccer players (n = 22; ages 17-19) performing 2 sets of 6 repeated sprints, with a single 2.5-minute CryoTherm™ Palm application between sets. Results compare intervention to control conditions and may not reflect outcomes in other training contexts, athlete levels, age groups, or populations. Full study details at therabody.com/science.
Backed by direct scientific research with elite collegiate and youth athletes, CryoTherm Palm's cooling technology made its debut with the England national team supporting training camps, pre-tournament friendlies, and sideline recovery protocols
LOS ANGELES, June 8, 2026 /PRNewswire/ -- Therabody®, the global wellness technology leader, today announced the launch of CryoTherm Palm, marking both a new addition to the brand's performance line and its entrance into the emerging thermoregulation category. CryoTherm Palm is the only palm cooling device validated through two controlled studies with statistically significant results ahead of its launch, delivering science-backed palm cooling that lowers core body temperature between high-intensity efforts to delay fatigue, reduce perceived exertion, and sustain output.
CryoTherm Palm is a portable, cordless device with dual cooling surfaces, for each palm, engineered for use during natural rest periods between sets, at halftime, during timeouts, water breaks, or across any high-intensity interval training or competition. Therabody's proprietary Cryothermal technology delivers scientifically calibrated cooling that maintains a therapeutic temperature range for the full duration of treatment, with no ice, water, or setup. Beyond palm cooling, it also delivers localized cold therapy, localized heat therapy, and contrast therapy, giving athletes and performance staff a single device for both in-session performance and post-session recovery.
Additional CryoTherm Palm features:
- Three scientifically calibrated cold temperature levels (46.4°F / 8°C, 53.6°F / 12°C, 60.8°F / 16°C) powered by proprietary Cryothermal Technology
- LCD display with stopwatch for treatment duration tracking and temperature status indicators
- Setting memory recalls last-used settings for quick start
- Up to 120 minutes of battery life; charges via USB-C
- Anti-roll, portable design with travel lock and included travel pouch
- Learn more about the science and technology behind CryoTherm Palm on Therabody's blog
The launch comes as elite athletes prepare to compete in summer heat, where managing body temperature and recovery can be critical to performance. England's national football team has incorporated CryoTherm Palm into its pre-tournament preparations, using the device throughout training camp ahead of the upcoming matches.
CryoTherm Palm is the only palm cooling device validated in two controlled studies: one with Division I athletes at the University of Southern California focused on strength training, and a second with elite soccer players at IMG Academy performing repeated sprint efforts. The results uncovered:
- 28% more total work volume during resistance training vs. control*
- 58% more reps in the final set vs. control*
- 7% increase in post-session grip strength vs. control*
- Athletes felt 60% cooler during repeated sprint efforts**
- 2.45% increase in top sprint speed vs. control**
- 4.7% better sprint velocity maintained across repeated all-out efforts**
- More information on the study findings can be found in the following research summaries: Therabody x University of Southern California, Therabody x IMG Academy
"Our mission has always been to help people feel better and perform at their best," says Tim Roberts, Chief Science Officer, Therabody. "CryoTherm Palm extends that mission into the training session itself—helping athletes delay fatigue, sustain intensity, and get more out of every effort. Whether it's a soccer player staying dangerous in the 85th minute or a strength athlete pushing through a final set, this product was designed and proven to make a measurable difference."
CryoTherm Palm is TSA compliant and registered as a Class 2 Exempt Medical Device in the United States and a Class 2 Medical Device in Canada. The product is available for purchase now at an MSRP of $399.99 in the United States on Therabody.com, with international availability in the EU, UK, Australia, and Canada coming fall 2026.
ABOUT THERABODY
Therabody® is the global wellness technology leader with a mission to empower every body to feel better and move better. Founded by Dr. Jason Wersland in 2016, the company combines science, innovation, and design to create products that optimize human performance and recovery. Recognized as one of Fast Company's Most Innovative Companies of 2026 and TIME's Best Inventions of 2025, Therabody continues to set the standard for wellness innovation. Its ecosystem includes the Theragun, JetBoots, PowerDot, TheraFace, and TheraCup, as well as digital wellness content and in-person experiences through Reset® by Therabody. For more information, visit Therabody.com or follow @Therabody on social media.
*Results from a randomized crossover study conducted with University of Southern California involving D1 collegiate athletes (n = 21) performing 4 sets of overhead presses to failure at 85% 1RM, with a single inter-set CryoTherm™ Palm application between sets. Results compare intervention to control conditions and may not reflect outcomes in other training contexts, athlete levels, or populations. Full study details at therabody.com/science.
**Results from a randomized crossover study conducted at IMG Academy in collaboration with University of Florida involving elite male soccer players (n = 22; ages 17-19) performing 2 sets of 6 repeated sprints, with a single 2.5-minute CryoTherm™ Palm application between sets. Results compare intervention to control conditions and may not reflect outcomes in other training contexts, athlete levels, age groups, or populations. Full study details at therabody.com/science.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
THERABODY LAUNCHES CRYOTHERM™ PALM, ITS FIRST THERMOREGULATION PERFORMANCE DEVICE, BRINGING SCIENCE-BACKED PALM COOLING TO MANAGE HEAT ON SPORT'S BIGGEST STAGE
|
JAKARTA, Indonesia, June 9, 2026 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC), together with Tourism Malaysia, recorded strong visitor engagement at Malaysia Fair Jakarta 2026, held from 4 to 7 June 2026 at Gandaria City, underscoring sustained interest among Indonesian consumers in Malaysia's healthcare, wellness and travel offerings. Organised in conjunction with Malaysia Year of Medical Tourism 2026 (MYMT 2026), themed "Healing Meets Hospitality", the initiative brings together healthcare providers, tourism stakeholders and educational institutions under one roof, offering Indonesian visitors exclusive access to world-class healthcare services, travel experiences and study opportunities.
A key highlight of the fair was the participation of 20 Malaysian healthcare providers including MHTC's Flagship Medical Tourism Hospitals namely Island Hospital Penang, Institut Jantung Negara, Mahkota Medical Centre, and Subang Jaya Medical Centre, alongside its member hospitals such as Alpha IVF & Women's Specialists, Ampang Puteri Specialist Hospital, Cengild G.I Medical Centre, Damansara Specialist Hospital, Damansara Specialist Hospital 2, GenPrime Everlink Fertility Centre, Hospital Picaso, MSU Medical Centre, Northern Heart Hospital Penang, OasisEye Specialists, Optimax Eye Specialist Centre, Penang Adventist Hospital, Puteri Specialist Hospital, Regency Specialist Hospital, Sunway Medical Centre, and Sunway Medical Centre Penang.
For those looking to book vacations, seven top travel agencies, including Dwidaya Tour, TX Travel, Habibi Tours, Baltic Golf & Travel Specialist, A&L Holidays, AWB Cruise, and Golden Rama Tours & Travel, are on-site, offering curated leisure packages alongside the official airline partner, Malaysia Airlines. Beyond health and travel, renowned higher education institutions such as Taylor's University, UCSI University, INTI International University, Todak Academy, and MILA University are on hand to consult with prospective students and parents. Visitors are given a range of travel and medical offerings to choose from, spanning specialist healthcare services, wellness experiences, tourism packages and destination showcases, as well as direct engagements with Malaysian healthcare providers.
"Malaysia Fair 2026 reflects our continued commitment to strengthening Malaysia Healthcare's presence in Indonesia, particularly in Jakarta, as one of our most important and high-potential markets. Through this platform, we aim to bring trusted Malaysian healthcare closer to Indonesian communities while reinforcing Malaysia's position as a preferred destination for quality healthcare, compassionate care, and seamless patient experience," said Mr Suriaghandi Suppiah, Chief Executive Officer of MHTC.
The fair was officially launched in the presence of MHTC's brand ambassador, Dato' Sri Siti Nurhaliza, whose participation underscored Malaysia's broader efforts to promote the country's medical tourism industry through a combination of medical excellence, hospitality, and cultural familiarity. As one of Malaysia's most recognised public figures with a strong following in Indonesia, Dato' Sri Siti Nurhaliza highlighted the importance of leveraging people-to-people connections to strengthen confidence in Malaysia's healthcare among regional audiences. "My TTC journey took almost 10 years, and I understand how important it is for patients to receive not only quality treatment but also reassurance, understanding, and hope throughout the process. As a Malaysian, I am proud to help share the strengths of Malaysia Healthcare with our friends in Indonesia and the wider region," she said.
The initiative comes at a time when Indonesia remains Malaysia Healthcare's largest and most important source market. In 2025 alone, Indonesia contributed approximately RM2.2 billion in healthcare travel revenue to Malaysia, representing a 23% year-on-year increase in revenue and a 16% increase in healthcare traveller arrivals compared to 2024. Meanwhile, over 970,000 Indonesian healthcare travelers visited Malaysia, indicating ongoing trust in Malaysia's healthcare system. Major treatment areas for Indonesian patients include health screening, gastroenterology, cancer treatment, endocrinology, cardiology, and orthopaedic surgery, highlighting Malaysia's capability to provide wide-ranging and specialized care for regional patients.
The event is also supported by strategic partners including Econolab, JavaMifi, Sheraton Grand Jakarta Gandaria City Hotel and Batik Air, whose participation further enhances the overall visitor experience and strengthens cross-industry collaboration in support of Malaysia Healthcare's outreach efforts in Indonesia.
ENDS
For media inquiries and further information, please contact:
Siti Hamidah Mohd Najib
Senior Executive, PR and Media Unit
Communications
+603 8776 6168
hamidah.m@mhtc.org.my
Mohamad Shahizam Fauzi
Head, Communications
+603 8776 6168
shahizam.f@mhtc.org.my
About Malaysia Healthcare Travel Council
Malaysia Healthcare Travel Council (MHTC), established in 2009 under the purview of the Ministry of Health (MOH) Malaysia, is entrusted with developing and nurturing the "Malaysia Healthcare" brand. MHTC enhances, coordinates, and promotes Malaysia's healthcare travel industry by fostering industry collaborations and building valuable public-private partnerships both domestically and internationally. With 82 member hospitals nationwide, MHTC continues to elevate the healthcare travel ecosystem through strong branding, seamless patient experiences, and strategic market initiatives. In line with these efforts, MHTC is spearheading the Malaysia Year of Medical Tourism (MYMT) 2026, the nation's first dedicated year to celebrate and advance healthcare travel. MYMT 2026 serves as a milestone initiative to showcase Malaysia's world-class healthcare offerings, strengthen its position as the premier global healthcare destination, and highlight the industry's significant contribution to the national economy. MHTC's website: https://www.malaysiahealthcare.org.
JAKARTA, Indonesia, June 9, 2026 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC), together with Tourism Malaysia, recorded strong visitor engagement at Malaysia Fair Jakarta 2026, held from 4 to 7 June 2026 at Gandaria City, underscoring sustained interest among Indonesian consumers in Malaysia's healthcare, wellness and travel offerings. Organised in conjunction with Malaysia Year of Medical Tourism 2026 (MYMT 2026), themed "Healing Meets Hospitality", the initiative brings together healthcare providers, tourism stakeholders and educational institutions under one roof, offering Indonesian visitors exclusive access to world-class healthcare services, travel experiences and study opportunities.
A key highlight of the fair was the participation of 20 Malaysian healthcare providers including MHTC's Flagship Medical Tourism Hospitals namely Island Hospital Penang, Institut Jantung Negara, Mahkota Medical Centre, and Subang Jaya Medical Centre, alongside its member hospitals such as Alpha IVF & Women's Specialists, Ampang Puteri Specialist Hospital, Cengild G.I Medical Centre, Damansara Specialist Hospital, Damansara Specialist Hospital 2, GenPrime Everlink Fertility Centre, Hospital Picaso, MSU Medical Centre, Northern Heart Hospital Penang, OasisEye Specialists, Optimax Eye Specialist Centre, Penang Adventist Hospital, Puteri Specialist Hospital, Regency Specialist Hospital, Sunway Medical Centre, and Sunway Medical Centre Penang.
For those looking to book vacations, seven top travel agencies, including Dwidaya Tour, TX Travel, Habibi Tours, Baltic Golf & Travel Specialist, A&L Holidays, AWB Cruise, and Golden Rama Tours & Travel, are on-site, offering curated leisure packages alongside the official airline partner, Malaysia Airlines. Beyond health and travel, renowned higher education institutions such as Taylor's University, UCSI University, INTI International University, Todak Academy, and MILA University are on hand to consult with prospective students and parents. Visitors are given a range of travel and medical offerings to choose from, spanning specialist healthcare services, wellness experiences, tourism packages and destination showcases, as well as direct engagements with Malaysian healthcare providers.
"Malaysia Fair 2026 reflects our continued commitment to strengthening Malaysia Healthcare's presence in Indonesia, particularly in Jakarta, as one of our most important and high-potential markets. Through this platform, we aim to bring trusted Malaysian healthcare closer to Indonesian communities while reinforcing Malaysia's position as a preferred destination for quality healthcare, compassionate care, and seamless patient experience," said Mr Suriaghandi Suppiah, Chief Executive Officer of MHTC.
The fair was officially launched in the presence of MHTC's brand ambassador, Dato' Sri Siti Nurhaliza, whose participation underscored Malaysia's broader efforts to promote the country's medical tourism industry through a combination of medical excellence, hospitality, and cultural familiarity. As one of Malaysia's most recognised public figures with a strong following in Indonesia, Dato' Sri Siti Nurhaliza highlighted the importance of leveraging people-to-people connections to strengthen confidence in Malaysia's healthcare among regional audiences. "My TTC journey took almost 10 years, and I understand how important it is for patients to receive not only quality treatment but also reassurance, understanding, and hope throughout the process. As a Malaysian, I am proud to help share the strengths of Malaysia Healthcare with our friends in Indonesia and the wider region," she said.
The initiative comes at a time when Indonesia remains Malaysia Healthcare's largest and most important source market. In 2025 alone, Indonesia contributed approximately RM2.2 billion in healthcare travel revenue to Malaysia, representing a 23% year-on-year increase in revenue and a 16% increase in healthcare traveller arrivals compared to 2024. Meanwhile, over 970,000 Indonesian healthcare travelers visited Malaysia, indicating ongoing trust in Malaysia's healthcare system. Major treatment areas for Indonesian patients include health screening, gastroenterology, cancer treatment, endocrinology, cardiology, and orthopaedic surgery, highlighting Malaysia's capability to provide wide-ranging and specialized care for regional patients.
The event is also supported by strategic partners including Econolab, JavaMifi, Sheraton Grand Jakarta Gandaria City Hotel and Batik Air, whose participation further enhances the overall visitor experience and strengthens cross-industry collaboration in support of Malaysia Healthcare's outreach efforts in Indonesia.
ENDS
For media inquiries and further information, please contact:
Siti Hamidah Mohd Najib
Senior Executive, PR and Media Unit
Communications
+603 8776 6168
hamidah.m@mhtc.org.my
Mohamad Shahizam Fauzi
Head, Communications
+603 8776 6168
shahizam.f@mhtc.org.my
About Malaysia Healthcare Travel Council
Malaysia Healthcare Travel Council (MHTC), established in 2009 under the purview of the Ministry of Health (MOH) Malaysia, is entrusted with developing and nurturing the "Malaysia Healthcare" brand. MHTC enhances, coordinates, and promotes Malaysia's healthcare travel industry by fostering industry collaborations and building valuable public-private partnerships both domestically and internationally. With 82 member hospitals nationwide, MHTC continues to elevate the healthcare travel ecosystem through strong branding, seamless patient experiences, and strategic market initiatives. In line with these efforts, MHTC is spearheading the Malaysia Year of Medical Tourism (MYMT) 2026, the nation's first dedicated year to celebrate and advance healthcare travel. MYMT 2026 serves as a milestone initiative to showcase Malaysia's world-class healthcare offerings, strengthen its position as the premier global healthcare destination, and highlight the industry's significant contribution to the national economy. MHTC's website: https://www.malaysiahealthcare.org.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Strong Indonesian Demand Reinforces Malaysia Healthcare's Growth at Malaysia Fair 2026
